Emmaus Life Sciences Inc (EMMA)
0.105
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Emmaus Life Sciences 1 Year Total Returns (Daily): -59.30% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 09, 2024 | -59.30% |
| May 08, 2024 | -66.67% |
| May 07, 2024 | -64.25% |
| May 06, 2024 | -64.25% |
| May 03, 2024 | -68.75% |
| May 02, 2024 | -68.27% |
| May 01, 2024 | -68.75% |
| April 30, 2024 | -68.25% |
| April 29, 2024 | -68.25% |
| April 26, 2024 | -66.67% |
| April 25, 2024 | -70.59% |
| April 24, 2024 | -67.74% |
| April 23, 2024 | -72.09% |
| April 22, 2024 | -72.09% |
| April 19, 2024 | -72.09% |
| April 18, 2024 | -65.53% |
| April 17, 2024 | -66.54% |
| April 16, 2024 | -65.53% |
| April 15, 2024 | -68.18% |
| April 12, 2024 | -67.20% |
| April 11, 2024 | -67.20% |
| April 10, 2024 | -68.37% |
| April 09, 2024 | -68.37% |
| April 08, 2024 | -68.37% |
| April 05, 2024 | -64.11% |
| Date | Value |
|---|---|
| April 04, 2024 | -65.94% |
| April 03, 2024 | -65.23% |
| April 02, 2024 | -65.29% |
| April 01, 2024 | -62.40% |
| March 28, 2024 | -68.18% |
| March 27, 2024 | -65.59% |
| March 26, 2024 | -73.53% |
| March 25, 2024 | -73.53% |
| March 22, 2024 | -72.16% |
| March 21, 2024 | -66.32% |
| March 20, 2024 | -76.32% |
| March 19, 2024 | -77.46% |
| March 18, 2024 | -73.39% |
| March 15, 2024 | -71.11% |
| March 14, 2024 | -71.25% |
| March 13, 2024 | -68.06% |
| March 12, 2024 | -71.82% |
| March 11, 2024 | -72.18% |
| March 08, 2024 | -72.13% |
| March 07, 2024 | -72.10% |
| March 06, 2024 | -71.36% |
| March 05, 2024 | -74.75% |
| March 04, 2024 | -72.50% |
| March 01, 2024 | -68.25% |
| February 29, 2024 | -68.78% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.15%
Minimum
Oct 12 2022
118.1%
Maximum
Oct 14 2021
-45.14%
Average
-61.82%
Median
Aug 13 2020
1 Year Total Returns (Daily) Benchmarks
| AIM ImmunoTech Inc | -10.90% |
| Perspective Therapeutics Inc | 176.5% |
| Protalix BioTherapeutics Inc | -57.19% |
| Electromed Inc | 63.47% |
| Armata Pharmaceuticals Inc | 154.7% |